KDIGO and aHUS treatment guidelines
KDIGO stands for Kidney Disease: Improving Global Outcomes. It is a global nonprofit organization that develops and publishes clinical practice guidelines…
Atypical HUS Research: What’s New for Sept 2023?
Atypical HUS research highlights for Sept 2023 - additions to our aHUS-specific research library
Atypical HUS Facts: 2023 – Sept – 2024
Atypical HUS Fact Sheet: 2023 SEPT 2024 An informational resource from the global advocates at aHUS Alliance Global Action
The early days of aHUS Research (Before aHUS Endeavours Fade)
Global Action is privileged to present a second article in the series BEFORE aHUS ENDEAVOURS FADE. Celebrating the work of people…
Numbers about aHUS
The first thing about aHUS numbers is that there is no exact record of global aHUS patients anywhere . But research…
A rose by any other name revisited
One of the most widely read articles on this website has been an article about aHUS name The rose article was…
Biosimilars – a Different type of aHUS Drug
Biosimilar drugs are having an increased presence in conversations about the aHUS therapeutic drug landscape. Here's why they're of interest.
ADAMTS13 Testing: Fast 4 TMA Program
USTMA has partnered with Machaon Diagnostics to offer free ADAMTS13 testing through the new ‘Fast 4 TMA’ program for patients in…
Cause or effect aHUS/IBD
In crime programmes when someone lands on the ground from a great height the question asked is “were they pushed or…
- Go to the previous page
- 1
- …
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- …
- 52
- Go to the next page